Clinical Features of Bipolar Disorder With and Without Comorbid Diabetes Mellitus

Canadian Journal of Psychiatry

Volumn 48, Issue 7, 2003, Pages 458-461

  Ruzickova, Martina ^a   Slaney, Claire ^a   Garnham, Julie ^a   Alda, Martin ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Bipolar disorder; Characteristics; Clinical; Clinical correlates; Clinical course; Comorbidity; Diabetes mellitus

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; BIPOLAR DISORDER; BODY MASS; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISABILITY; DISEASE COURSE; FEMALE; GENETIC LINKAGE; GLOBAL ASSESSMENT OF FUNCTIONING SCALE; HEALTH CARE COST; HUMAN; HYPERTENSION; LIFESPAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROGNOSIS; REGISTER; REVIEW; SCORING SYSTEM; SIGNAL TRANSDUCTION; SOCIOECONOMICS;

EID: 0142090422     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370304800705     Document Type: Review

References (16)

1. Van der Velde CD, Gordon MW. Manic-depressive illness, diabetes mellitus, and lithium carbonate. Arch Gen Psychiatry 1969;21:478-85.
2. Vendsborg PB. Lithium treatment and glucose tolerance in manic-melancholic patients. Acta Psychiatr Scand 1979;59:306-16.
3. Vestergaard P, Schou M. Does long-term lithium treatment induce diabetes mellitus? Neuropsychobiology 1987;17:130-2.
4. Heninger GR, Mueller PS. Carbohydrate metabolism in mania before and after lithium carbonate treatment. Arch Gen Psychiatry 1970;23:310-9.
5. Mueller PS, Heninger GR, McDonald RK. Insulin tolerance test in depression. Arch Gen Psychiatry 1969;21:587-94.
6. Lilliker SL. Prevalence of diabetes in a manic-depressive population. Compr Psychiatry 1980;21:270-5.
7. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999;156:1417-20.
8. Regenold WT, Thapar RK, Marano C, Gavimeni S, Kondapavuluru PV. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with BD I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002;70:19-26.
9. Lustman PJ, Griffith LS, Clouse RE, Cryer PE. Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv Ment Dis 1986;174:736-42.
10. American Psychiatric Association. Diagnostic and statistical manual for mental disorders. 4th ed. Washington (DC): APA; 1994.
11. Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, and others. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 2000;157:975-81.
12. Gianfrancesco FD, Grogg AL, Mahmoud RA, Wang RH, Nasrallah HA. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. J Clin Psychiatry 2002;63:920-30.
13. Liebzeit KA, Markowitz JS, Caley CF. New onset diabetes and atypical antipsychotics. Eur Neuropsychopharmacol 2001;11:25-32.
14. Mannisto P, Koivisto V. Antidiabetic effects of lithium. Lancet 1972;2:1031.
15. Rossetti L. Normalization of insulin sensitivity with lithium in diabetic rats. Diabetes 1989;38:648-52.
16. Orena SJ, Torchia AJ, Garofalo RS. Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes. J Biol Chem 2000;275:15765-72.